TY - JOUR
T1 - Vardenafil is effective and well-tolerated for treating erectile dysfunction in a broad population of men, irrespective of age
AU - Giuliano, François
AU - Donatucci, Craig
AU - Montorsi, Francesco
AU - Auerbach, Stephen
AU - Karlin, Gary
AU - Norenberg, Christiane
AU - Homering, Martin
AU - Segerson, Thomas
AU - Eardley, Ian
PY - 2005/1
Y1 - 2005/1
N2 - OBJECTIVES: To assess the efficacy and safety of vardenafil in the treatment of erectile dysfunction (ED) in men of different age groups. PATIENTS AND METHODS: In a retrospective pooled subgroup analysis of randomized, double-blind, placebo-controlled studies, men from the general population with ED received either placebo or vardenafil 5, 10 or 20 mg over 12 weeks. Efficacy variables included the erectile function (EF) domain score from The International Index of Erectile Function, diary response rates to questions on vaginal penetration and maintenance of erection, and positive responses to the Global Assessment Question (GAQ) 'Has the treatment you have been taking over the past 4 weeks improved your erections?'. The 1385 men were grouped by age (
AB - OBJECTIVES: To assess the efficacy and safety of vardenafil in the treatment of erectile dysfunction (ED) in men of different age groups. PATIENTS AND METHODS: In a retrospective pooled subgroup analysis of randomized, double-blind, placebo-controlled studies, men from the general population with ED received either placebo or vardenafil 5, 10 or 20 mg over 12 weeks. Efficacy variables included the erectile function (EF) domain score from The International Index of Erectile Function, diary response rates to questions on vaginal penetration and maintenance of erection, and positive responses to the Global Assessment Question (GAQ) 'Has the treatment you have been taking over the past 4 weeks improved your erections?'. The 1385 men were grouped by age (
KW - Elderly
KW - Erectile dysfunction
KW - Oral PDE-5 inhibitors
KW - Placebo-controlled clinical trial
UR - http://www.scopus.com/inward/record.url?scp=12544256530&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=12544256530&partnerID=8YFLogxK
U2 - 10.1111/j.1464-410X.2004.05260.x
DO - 10.1111/j.1464-410X.2004.05260.x
M3 - Article
C2 - 15638906
AN - SCOPUS:12544256530
VL - 95
SP - 110
EP - 116
JO - BJU International
JF - BJU International
SN - 1464-4096
IS - 1
ER -